Ribozymes may be the new destroyer of AIDS; Study ranks San Diego #1 among U.S. biotech centers; Nonprofit to bring biotech benefits to developing countries; Merck/Imclone cancer vaccine fails; future uncertain; Biosante's oral insulin delivery technology works in mouse model.
展开▼
